Gravar-mail: [(68)Ga]Ga-P16-093 as a PSMA-Targeted PET Radiopharmaceutical for Detection of Cancer: Initial Evaluation and Comparison with [(68)Ga]Ga-PSMA-11 in Prostate Cancer Patients Presenting with Biochemical Recurrence